Potency classification of topical corticosteroids: modern perspectives

Area of Science:

• Dermatology
• Immunology
• Pharmacology

Background:

• Topical corticosteroids are widely used for inflammatory skin conditions.
• Their effects on immune cells within the epidermis, such as Langerhans cells, are significant.
• Understanding these effects is crucial for optimizing treatment and assessing drug potency.

Purpose of the Study:

• To investigate the impact of topical corticosteroid therapy on human epidermal Langerhans cell surface markers.
• To evaluate whether changes in Langerhans cell numbers and function correlate with corticosteroid potency.
• To determine the utility of Langerhans cell assessment as an adjunct method for measuring steroid potency.

Main Methods:

• Human skin samples treated with topical corticosteroids were analyzed.
• Langerhans cells were identified and enumerated using surface markers like human leukocyte antigen-DR (HLA-DR) and T6.
• The alloantigen-presenting capacity of epidermal cells was assessed to evaluate Langerhans cell function.

Main Results:

• A reduction in the number of HLA-DR+/T6+ Langerhans cells was observed, correlating with corticosteroid potency.
• Corticosteroid therapy also diminished the alloantigen-presenting capacity of epidermal cells.
• Functional assessments were found to be less reproducible due to experimental variability and residual cell potency.

Conclusions:

• Langerhans cell enumeration can serve as a useful adjunct for assessing topical corticosteroid potency.
• While corticosteroid therapy affects Langerhans cell function, functional assays are not currently recommended for potency measurement due to reproducibility issues.
• Further research may refine functional assays for more reliable potency assessment.